O’Neal Cancer Center Announces Recipients of Cancer-Related Research Grants Through the O’Neal Invests Spring 2025 Cycle

The UAB O’Neal Cancer Center is pleased to announce the latest O’Neal Invests grant awards. O’Neal Invests grants fund UAB investigators initiating new cancer-related projects to do key preliminary work to enable competitive extramural applications. Applications for the eleventh grant cycle were submitted in spring 2025.

The awardees receiving funding through O’Neal Invests include:

• Carlene Zindl, Ph.D.
  • Department of Pathology
  • Division of Molecular and Cellular Pathology
  • Pre-R01
  • Dissecting Regional Epithelial and Immune Cell Heterogeneity in Colorectal Cancer
• Blake Eason Hildreth, Ph.D.
  • Department of Pathology
  • Division of Molecular and Cellular Pathology
  • Pre-R01
  • Evaluation of the Role of PU.1 in Clear Cell Renal Cell Carcinoma Progression
• Angela Carter, Ph.D.
  • Department of Surgery
  • Division of Surgical Oncology
  • Catalyst
  • The Role of Amphetamine in Microbiome Alterations that Promote Colo-Rectal Cancer

There are two O’Neal Invests RFAs per year, in the spring and fall. O’Neal Cancer Center membership is not a requirement to apply, but awardees must become members. The grants are peer-reviewed by a panel of UAB faculty.

In addition to these grants, two additional awards were funded through the generosity of the Breast Cancer Research Foundation of Alabama (BCRFA); read more about these awardees here.